Inovio Pharma plunges on planned equity offering
29/07/2026 21:20
BUZZ-Inovio Pharma plunges on planned equity offering ** Inovio Pharmaceuticals' INO.O shares plunge 19.2% to record low 84 cents post-market as co looks to raise equity
** Co focused on treating HPV-related diseases, cancer, and infectious diseases, intends to offer shares and accompanying warrants; deal size not disclosed
** Piper Sandler sole bookrunner
** Plymouth Meeting, Pennsylvania-based firm has ~82.3 mln shares outstanding
** INO shares finished up 1% at $1.04 on Weds, trimming YTD loss to 40%
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million